2020 AACA意见书:急性心肌梗死的质量指标

2021-02-07 急性心血管保健协会 Eur Heart J Acute Cardiovasc Care . 2021 Feb 7.

2021年2月,急性心血管保健协会(AACA)更新发布了急性心肌梗死的质量指标。本文是对2017年版急性心肌梗死质量指标的更新,专家组依据最新的知识和积累的经验,制定了急性心肌梗死管理的最新质量指标,

中文标题:

2020 AACA意见书:急性心肌梗死的质量指标

英文标题:

2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group

发布机构:

急性心血管保健协会

发布日期:

2021-02-07

简要介绍:

2021年2月,急性心血管保健协会(AACA)更新发布了急性心肌梗死的质量指标。本文是对2017年版急性心肌梗死质量指标的更新,专家组依据最新的知识和积累的经验,制定了急性心肌梗死管理的最新质量指标,用于评估个改善心肌梗死的管理质量。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 AACA意见书:急性心肌梗死的质量指标.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ab7431c00206a1b7, title=2020 AACA意见书:急性心肌梗死的质量指标, enTitle=2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group, guiderFrom=Eur Heart J Acute Cardiovasc Care . 2021 Feb 7., authorId=0, author=, summary=2021年2月,急性心血管保健协会(AACA)更新发布了急性心肌梗死的质量指标。本文是对2017年版急性心肌梗死质量指标的更新,专家组依据最新的知识和积累的经验,制定了急性心肌梗死管理的最新质量指标,, cover=https://img.medsci.cn/2021223/1614012064701_2020535.jpg, journalId=0, articlesId=null, associationId=1257, associationName=急性心血管保健协会, associationIntro=, copyright=0, guiderPublishedTime=Sun Feb 07 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年2月,急性心血管保健协会(AACA)更新发布了急性心肌梗死的质量指标。本文是对2017年版急性心肌梗死质量指标的更新,专家组依据最新的知识和积累的经验,制定了急性心肌梗死管理的最新质量指标,用于评估个改善心肌梗死的管理质量。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=678, tagName=急性心肌梗死)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=678, guiderKeyword=急性心肌梗死, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=18470, appHits=362, showAppHits=0, pcHits=1249, showPcHits=18106, likes=2, shares=25, comments=8, approvalStatus=1, publishedTime=Tue Feb 23 00:55:10 CST 2021, publishedTimeString=2021-02-07, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Tue Feb 23 00:41:11 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 21:31:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 AACA意见书:急性心肌梗死的质量指标.pdf)])
2020 AACA意见书:急性心肌梗死的质量指标.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1003649, encodeId=57f1100364931, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrkxoDevqNYXl2g8j2888icKj35fkVKYBfEicTnvfvTvg4yzjZ1yg5pyOxDv99xZd73tLlGEbPX1Gw/132, createdBy=a5932555882, createdName=125507ecm23暂无昵称, createdTime=Thu Jul 29 20:21:27 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001937, encodeId=55ae100193e1a, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24935408380, createdName=Grandir, createdTime=Fri Jul 23 09:51:23 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957131, encodeId=406495e1317f, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:01:48 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953254, encodeId=f93a953254ee, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0EYArZX3Ab6o0fnwgKY35Eiau72ZvtcWXhibj7qtUyLhTF3hbR2fuZSd3NkLtY3XO6coKSubqRbP1biagvzWwiap4A/132, createdBy=6db02491761, createdName=gyt1214, createdTime=Fri Apr 02 10:29:07 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953252, encodeId=4d97953252b1, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0EYArZX3Ab6o0fnwgKY35Eiau72ZvtcWXhibj7qtUyLhTF3hbR2fuZSd3NkLtY3XO6coKSubqRbP1biagvzWwiap4A/132, createdBy=6db02491761, createdName=gyt1214, createdTime=Fri Apr 02 10:28:56 CST 2021, time=2021-04-02, status=1, ipAttribution=)]
    2021-07-29 125507ecm23暂无昵称

    可以

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1003649, encodeId=57f1100364931, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrkxoDevqNYXl2g8j2888icKj35fkVKYBfEicTnvfvTvg4yzjZ1yg5pyOxDv99xZd73tLlGEbPX1Gw/132, createdBy=a5932555882, createdName=125507ecm23暂无昵称, createdTime=Thu Jul 29 20:21:27 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001937, encodeId=55ae100193e1a, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24935408380, createdName=Grandir, createdTime=Fri Jul 23 09:51:23 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957131, encodeId=406495e1317f, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:01:48 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953254, encodeId=f93a953254ee, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0EYArZX3Ab6o0fnwgKY35Eiau72ZvtcWXhibj7qtUyLhTF3hbR2fuZSd3NkLtY3XO6coKSubqRbP1biagvzWwiap4A/132, createdBy=6db02491761, createdName=gyt1214, createdTime=Fri Apr 02 10:29:07 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953252, encodeId=4d97953252b1, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0EYArZX3Ab6o0fnwgKY35Eiau72ZvtcWXhibj7qtUyLhTF3hbR2fuZSd3NkLtY3XO6coKSubqRbP1biagvzWwiap4A/132, createdBy=6db02491761, createdName=gyt1214, createdTime=Fri Apr 02 10:28:56 CST 2021, time=2021-04-02, status=1, ipAttribution=)]
    2021-07-23 Grandir

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1003649, encodeId=57f1100364931, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrkxoDevqNYXl2g8j2888icKj35fkVKYBfEicTnvfvTvg4yzjZ1yg5pyOxDv99xZd73tLlGEbPX1Gw/132, createdBy=a5932555882, createdName=125507ecm23暂无昵称, createdTime=Thu Jul 29 20:21:27 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001937, encodeId=55ae100193e1a, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24935408380, createdName=Grandir, createdTime=Fri Jul 23 09:51:23 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957131, encodeId=406495e1317f, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:01:48 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953254, encodeId=f93a953254ee, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0EYArZX3Ab6o0fnwgKY35Eiau72ZvtcWXhibj7qtUyLhTF3hbR2fuZSd3NkLtY3XO6coKSubqRbP1biagvzWwiap4A/132, createdBy=6db02491761, createdName=gyt1214, createdTime=Fri Apr 02 10:29:07 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953252, encodeId=4d97953252b1, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0EYArZX3Ab6o0fnwgKY35Eiau72ZvtcWXhibj7qtUyLhTF3hbR2fuZSd3NkLtY3XO6coKSubqRbP1biagvzWwiap4A/132, createdBy=6db02491761, createdName=gyt1214, createdTime=Fri Apr 02 10:28:56 CST 2021, time=2021-04-02, status=1, ipAttribution=)]
    2021-04-15 梅干儿

    三人行,必有我师。 #梅斯医学科研互助群# 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1003649, encodeId=57f1100364931, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrkxoDevqNYXl2g8j2888icKj35fkVKYBfEicTnvfvTvg4yzjZ1yg5pyOxDv99xZd73tLlGEbPX1Gw/132, createdBy=a5932555882, createdName=125507ecm23暂无昵称, createdTime=Thu Jul 29 20:21:27 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001937, encodeId=55ae100193e1a, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24935408380, createdName=Grandir, createdTime=Fri Jul 23 09:51:23 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957131, encodeId=406495e1317f, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:01:48 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953254, encodeId=f93a953254ee, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0EYArZX3Ab6o0fnwgKY35Eiau72ZvtcWXhibj7qtUyLhTF3hbR2fuZSd3NkLtY3XO6coKSubqRbP1biagvzWwiap4A/132, createdBy=6db02491761, createdName=gyt1214, createdTime=Fri Apr 02 10:29:07 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953252, encodeId=4d97953252b1, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0EYArZX3Ab6o0fnwgKY35Eiau72ZvtcWXhibj7qtUyLhTF3hbR2fuZSd3NkLtY3XO6coKSubqRbP1biagvzWwiap4A/132, createdBy=6db02491761, createdName=gyt1214, createdTime=Fri Apr 02 10:28:56 CST 2021, time=2021-04-02, status=1, ipAttribution=)]
    2021-04-02 gyt1214

    棒棒哒

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1003649, encodeId=57f1100364931, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrkxoDevqNYXl2g8j2888icKj35fkVKYBfEicTnvfvTvg4yzjZ1yg5pyOxDv99xZd73tLlGEbPX1Gw/132, createdBy=a5932555882, createdName=125507ecm23暂无昵称, createdTime=Thu Jul 29 20:21:27 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001937, encodeId=55ae100193e1a, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24935408380, createdName=Grandir, createdTime=Fri Jul 23 09:51:23 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957131, encodeId=406495e1317f, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:01:48 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953254, encodeId=f93a953254ee, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0EYArZX3Ab6o0fnwgKY35Eiau72ZvtcWXhibj7qtUyLhTF3hbR2fuZSd3NkLtY3XO6coKSubqRbP1biagvzWwiap4A/132, createdBy=6db02491761, createdName=gyt1214, createdTime=Fri Apr 02 10:29:07 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953252, encodeId=4d97953252b1, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0EYArZX3Ab6o0fnwgKY35Eiau72ZvtcWXhibj7qtUyLhTF3hbR2fuZSd3NkLtY3XO6coKSubqRbP1biagvzWwiap4A/132, createdBy=6db02491761, createdName=gyt1214, createdTime=Fri Apr 02 10:28:56 CST 2021, time=2021-04-02, status=1, ipAttribution=)]
    2021-04-02 gyt1214

    非常好

    0